meta_pixel
Tapesearch Logo
Log in
Economist Podcasts

More needles in the haystack: vaccine candidates proliferate

Economist Podcasts

The Economist

News & Politics, News

4.35K Ratings

🗓️ 1 February 2021

⏱️ 22 minutes

🧾️ Download transcript

Summary

That a coronavirus vaccine could be developed in a year is astonishing—and promising candidates just keep coming. How will the virus’s variants change the dynamic? Palestine may at last hold elections, after 15 years of promises. But Mahmoud Abbas, the incumbent president, may end up as the only viable candidate. And the probable first big market for lab-grown meat.

For full access to print, digital and audio editions of The Economist, subscribe here www.economist.com/intelligenceoffer


Hosted on Acast. See acast.com/privacy for more information.

Transcript

Click on a timestamp to play from that location

0:00.0

Hello and welcome to the Intelligence on Economist Radio. I'm your host, Jason Palmer.

0:09.7

Every weekday, we provide a fresh perspective on the events shaping your world.

0:17.7

There hasn't been an election in Palestine for more than 15 years.

0:22.8

Mahmoud Abbas keeps making noises about holding one, but it never really happens.

0:27.9

This time it might, but Mr. Abbas is likely to end up the only viable candidate.

0:33.5

So why bother?

0:36.2

And there's long been a push to make meat in laboratories,

0:40.4

to meet consumer demands for animal welfare and environmental friendliness.

0:45.2

But all things considered, it might not be people

0:47.7

that are the first big consumers of lab-grown meat.

0:55.8

First up, though,

0:58.5

just as soon as it became clear that a novel virus outbreak in China was going to become

1:05.6

a global concern, it became clear that the world would need a vaccine.

1:10.6

In those early days, that seemed impossibly distant. Vaccines it became clear that the world would need a vaccine.

1:11.2

In those early days, that seemed impossibly distant.

1:15.0

Vaccines often take the better part of a decade to develop and test.

1:19.4

Now just a year on, and several are already approved in many jurisdictions.

1:24.6

Then in the space of a day last week, encouraging results from two more.

1:29.5

But in that intervening year, the coronavirus has done what all viruses do.

1:34.6

It's mutated.

1:35.9

And that adds a complicating factor to an already complicated global rollout.

1:40.8

So the two vaccines are quite exciting.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from The Economist, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Economist and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.